Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Plecanatide effective for IBS with constipation Next Article
Possible causal link between eosinophilic inflammation and anxiety »
« Plecanatide effective for IBS with constipation Next Article
Possible causal link between eosinophilic inflammation and anxiety »
Table of Contents: UEGW 2020
Featured articles
Risk factors for severe COVID-19 among IBD patients
UEGW Round-Up Articles
Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease
Low-FODMAPs diet does not improve PPI-refractory GERD
Probiotic provides a potential adjuvant treatment to gluten-free diet
Cholecystectomy does not affect mortality in elderly patients
No improvements of remission with etrolizumab in ulcerative colitis
Filgotinib effective as maintenance treatment for ulcerative colitis
Possible causal link between eosinophilic inflammation and anxiety
Dupilumab improves in diverse aspects of eosinophilic oesophagitis
Plecanatide effective for IBS with constipation
Sustained response to faecal microbiota transplantation
Endoscopy can be delivered safely during the COVID-19 pandemic
Adenoma detection rate improves over time
Post-colonoscopy colorectal cancers in IBD patients
Risk factors for severe COVID-19 among IBD patients
First randomised T2T trial using endoscopy to guide dose escalation
Related Articles
April 12, 2022
Mirikizumab efficacious for active ulcerative colitis
April 30, 2021
Stopping infliximab linked to relapse in ulcerative colitis
February 17, 2021
Reassuring data on immune checkpoint inhibitors in autoimmune disease
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy